BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg...

30
hen to Challenge Requests! att Hazell, (Consultant Clinical Scientist Red Cell munohaematology)

Transcript of BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg...

Page 1: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

When to Challenge Requests!

Matt Hazell, (Consultant Clinical Scientist Red Cell Immunohaematology)

Page 2: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

What might a request be for?

Page 3: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

What might a request be for?

Blood productsRed cell units – normal, frozen, washed, irradiatedPlatelets – apheresis, in additive solution, washed, HLA or HPA selectedPlasma – FFP, Methylene Blue, Octaplas, CryoGranulocytes – apheresis, buffy coats, pooled buffy coatsPlasma derivatives – Human albumin solution, Clotting factor concentrates, Immunoglobulin solutions

Page 4: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

What might a request be for?

Blood productsRed cell units – normal, frozen, washed, irradiatedPlatelets – apheresis, in additive solution, washed, HLA or HPA selectedPlasma – FFP, Methylene Blue, Octaplas, CryoGranulocytes – apheresis, buffy coats, pooled buffy coatsPlasma derivatives – Human albumin solution, Clotting factor concentrates, Immunoglobulin solutions

Laboratory investigations

Page 5: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Why Challenge requests?

Page 6: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Why Challenge requests?

Safety and Appropriate useThe safest transfusion is one the patient never receives; prevent mistakesprevent waste, deviation from guidance/license

Page 7: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Why Challenge requests?

Safety and Appropriate useThe safest transfusion is on the patient never receives; prevent mistakesprevent waste, deviation from guidance/license

Potential shortageCategory 1 Category 2 Category 3

Active majorbleeding

Cancer surgery(palliative)

Urgent but notemergency

surgery

Electivesurgery, likely to

require Tx

Emergencysurgery

Not lifethreatening

anaemia

Life threateninganaemia

Page 8: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Why Challenge requests?

Safety and Appropriate useThe safest transfusion is on the patient never receives; prevent mistakesprevent waste, deviation from guidance/license

Potential shortage

Cost

Page 9: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Why Challenge requests?

Safety and Appropriate useThe safest transfusion is on the patient never receives; prevent mistakesprevent waste, deviation from guidance/license

Potential shortage

Cost

REMEMBER!Provide the right blood component(s), to the right patient at the right time

Page 10: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Challenge may be unwelcome…

Page 11: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Challenge may be unwelcome…

Delay treatment – emergency, theatre

Page 12: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Challenge may be unwelcome…

Delay treatment – emergency, theatreInconsistent advice

Page 13: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Challenge may be unwelcome…

Delay treatment – emergency, theatreInconsistent advicePerception of different priorities

Patient care Vs Financial imperativesTreatement Vs adverse effects

Page 14: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Challenge may be unwelcome…

Delay treatment – emergency, theatreInconsistent advicePerception of different priorities

Patient care Vs Financial imperativesTreatement Vs adverse effects

RepetitionTask; clinical information

Page 15: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Challenge may be unwelcome…

Delay treatment – emergency, theatreInconsistent advicePerception of different priorities

Patient care Vs Financial imperativesTreatement Vs adverse effects

RepetitionTask; clinical information

Requester is not impowered

Page 16: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Challenge may be unwelcome…

Delay treatment – emergency, theatreInconsistent advicePerception of different priorities

Patient care Vs Financial imperativesTreatement Vs adverse effects

RepetitionTask; clinical information

Requester is not impoweredRequester isn’t used to being challenged

Page 17: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

When to challenge requests?

Page 18: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

When to challenge requests?

Consider challenging requests when for:• Elective or prophylactic use• High cost products• Off-license, or where specific guidance

contradicts

Page 19: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

When to challenge requests?

Don’t challenge when there is:• Acute haemorrhage (for RBCs)

even if you haven’t had an up-to-date Hb etc.

• Requests for immediate O-(+)• When a delay in supply will further impact

(e.g. delaying critical procedures)

Consider challenging requests when for:• Elective or prophylactic use• High cost products• Off-license, or where specific guidance

contradicts

Page 20: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Example

Pre – operativePatients Hb is 90g/L3 units RBCs ordered

Page 21: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Example

Pre – operativePatients Hb is 90g/L3 units RBCs orderedBest managed with iron/EPO, is still low at surgery – TX acid (unless contraindicated)

Page 22: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Neutropenia• Patient is undergoing chemotherapy,

neutrophil count is 0.2x109/L, Patient has a bacterial infection

• Granulocyte order

Example

Page 23: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Neutropenia• Patient is undergoing chemotherapy,

neutrophil count is 0.2x109/L, Patient has a bacterial infection

• Granulocyte order• Best managed first with antibiotics

Example

Page 24: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Low platelet count• Patient has recoverable bone marrow

failure, neutropenic sepsis, antibiotics not been effective, granulocytes have been administered, platelet count before granulocyte transfusion was 10x109/L

• Platelets ordered

Example

Page 25: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Low platelet count• Patient has recoverable bone marrow

failure, neutropenic sepsis, antibiotics not been effective, granulocytes have been administered, platelet count before granulocyte transfusion was 10x109/L

• Platelets ordered• Granulocyte transfusions contain ~2 units

platelets

Example

Page 26: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Low platelet count• Patient is due to undergo lumbar puncture• Platelet count is 50x109/L• 1 unit platelet ordered

Example

Page 27: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Low platelet count• Patient is due to undergo lumbar puncture• Platelet count is 50x109/L• 1 unit platelet ordered• Procedure can be undertaken ≥40x109/L

Example

Page 28: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Anti-D Flow Cytometry• Long term inpatient - AML• Historic group O pos• On grouping, ?? D group• Patient is male• Investigation by flow cytometry ordered

Example

Page 29: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Anti-D Flow Cytometry• Long term inpatient - AML• Historic group O pos• On grouping, ?? D group• Patient is male• Investigation by flow cytometry ordered• Wouldn’t investigate by flow cytometry, patient

is historic D pos – would not be sensitised, patient is male and would not receive anti-D prophylaxis

Example

Page 30: BMS empowerment when to challenge - Transfusion Guidelines · :kdw pljkw d uhtxhvw eh iru" %orrg surgxfwv 5hg fhoo xqlwv ±qrupdo iur]hq zdvkhg luudgldwhg 3odwhohwv ±dskhuhvlv lq

Summary

Discuss unclear requests

Avoid issuing inappropriate products to prevent harm

Identify patterns of requesting that fall outside guidelines to improve future requesting and supply

Longer-term feeding back to requesters

via the online requesting system (if applicable) - automatic

hospital transfusion committee

summoning clinicians to account for their practice